Effect of a Plant-based Ingredient on Glucose Response
An Exploratory Study of a Plant-based Ingredient for Reducing the Post-prandial Blood Glucose Response in Healthy Indian Adults, When Administered With a Meal
1 other identifier
interventional
48
1 country
1
Brief Summary
The study is designed to determine the extent to which a plant-based ingredient is able to modulate blood glucose response when administered with a meal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Aug 2014
Shorter than P25 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 14, 2014
CompletedFirst Posted
Study publicly available on registry
August 18, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedFebruary 18, 2015
August 1, 2014
1 month
August 14, 2014
February 17, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Positive incremental post-prandial blood glucose area unde the curve
120 minutes
Secondary Outcomes (4)
Positive incremental post-prandial blood glucose area under the curve
180 minutes
Post-prandial insulin response
120 minutes
Post-prandial insulin response
180 minutes
Assessment of gastric emptying rate
10 hours
Other Outcomes (3)
Cmax
120 minutes
Cmax-baseline corrected
120 minutes
Tmax
120 minutes
Study Arms (6)
Starchy meal
PLACEBO COMPARATORNo Plant-based ingredient added to a starchy meal
Low dose added to starchy meal
ACTIVE COMPARATORPlant-based ingredient in low dose added to starchy meal
Starchy meal and side dish
PLACEBO COMPARATORNo Plant-based ingredient added to starchy meal and side dish
Low dose added to starchy meal and side dish
ACTIVE COMPARATORPlant-based ingredient in low dose added to starchy meal and side dish
Medium dose added to starchy meal and side dish
ACTIVE COMPARATORPlant-based ingredient in medium dose added to starchy meal and side dish
High dose added to starchy meal and side dish
ACTIVE COMPARATORPlant-based ingredient in high dose added to starchy meal and side dish
Interventions
Eligibility Criteria
You may qualify if:
- Healthy males and females, age at start of the study ≥ 18 and ≤ 50 years;
- Apparently healthy: no medical conditions which might affect the study measurements, as judged by study physician and/or measured by questionnaire, and/or assessed by haematology, blood chemistry and urinalysis;
- Fasting blood glucose value of subjects is ≥ 3.4 and ≤ 6.1 mmol/litre (i.e. 62-110 mg/dl) at screening;
- Haemoglobin level within clinically acceptable range (for male 12 to 17 gm/dL and for females 11 to 15 gm/dL; both inclusive) as judged by the research physician;
- Body mass index (BMI) ≥ 18,0 and ≤ 25,0 kg/m2;
- Agreeing to be informed about medically relevant personal test-results by study physician;
- Willing to comply to study protocol during study;
- Willing to refrain from drinking of alcohol on and one day before the blood withdrawal;
- Accessible veins on arms as determined by examination at screening;
- Being literate;
- HbA1C ≤ 6.5 % (48 mmol/mol).
You may not qualify if:
- Any history of diabetes, hyper- (or hypo-) glycemia or other disorder of glucose metabolism;
- Any history of gastro-intestinal disorders (including frequent diarrhoea for example);
- Blood donation in the past 2 months;
- Reported participation in another nutritional or biomedical trial 3 months before the pre-study examination or during the study;
- Reported participation in night shift work two weeks prior to pre-study investigation or during the study. Night work is defined as working between 23.00 PM and 6.00 AM;
- Reported intense sporting activities \> 10h/w;
- Consumption of ≥120 ml of alcoholic drinks for males and females in a typical week;
- Drug abuse as indicated by urine analysis;
- Chronic smokers, tobacco chewers and drinkers;
- Use of any medication, including supplements and traditional medicine;
- Reported dietary habits, such as a medically prescribed/slimming diet;
- Not being used to eat breakfast;
- Reported weight loss/gain (\>10%) in the last six month before the study;
- Being an employee of Unilever or CRO;
- Allergy or intolerance to food products and aversion to food products provided during the study;
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Unilever R&Dlead
Study Sites (1)
Lambda Therapeutics Research Ltd (LTRL)
Ahmedabad, India
Study Officials
- PRINCIPAL INVESTIGATOR
Dr. Ketul Modi, MBBS
Lambda Therapeutics Research Ltd (LTRL)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 14, 2014
First Posted
August 18, 2014
Study Start
August 1, 2014
Primary Completion
September 1, 2014
Study Completion
September 1, 2014
Last Updated
February 18, 2015
Record last verified: 2014-08